Ledger.Open graph →

SEC Form D · filed March 1, 2011

NIIKI PHARMA INC

Offering

$6.0M

Sold

$500K

Exemption

—

Industry

Biotechnology

Location

HOBOKEN, NJ

Type

—

People & firms on this filing (4)

Ali Ardakani · Hoboken, NJExec · Director Hooshmand Sheshbaradaran · Hoboken, NJExec · Director Jeffrey S. Podell · Miami, FLExec · Director Richard J. Rosenstock · Miami, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗